Antisense Therapeutics CEO Mark Diamond presents at the ShareCafe Hidden Gems Webinar on June 26, 2020. Antisense is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The products are in-licensed from Ionis Pharmaceuticals Inc. (NASDAQ: IONS), an established leader in antisense drug development.